Isik Turker Takeru Makiyama Matteo Vatta Hideki Itoh Takeshi Ueyama Akihiko Shimizu Tomohiko Ai Minoru Horie
10.1371/journal.pone.0161872
PLoS One
2016 Aug 25;11(8):e0161872.
CC BY
https://pubmed.ncbi.nlm.nih.gov/27560382/
Anti-Arrhythmia Agents / adverse effects Brugada Syndrome / genetics Mutation, Missense NAV1.5 Voltage-Gated Sodium Channel / genetics
Anti-Arrhythmia Agents / adverse effects Brugada Syndrome / genetics Mutation, Missense NAV1.5 Voltage-Gated Sodium Channel / genetics Case Reports Aged Atrial Fibrillation / drug therapy Atrial Fibrillation / physiopathology Atrial Flutter / drug therapy Atrial Flutter / physiopathology Base Sequence Brugada Syndrome / chemically induced Brugada Syndrome / physiopathology DNA Mutational Analysis Electrocardiography HEK293 Cells Humans Lidocaine / adverse effects Lidocaine / analogs & derivatives Male Anti-Arrhythmia Agents NAV1.5 Voltage-Gated Sodium Channel SCN5A protein, human Lidocaine pilsicainide
PMC4999187
27560382
A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG
2016